Concepedia

Author

Krikor Bornazyan

University of California, Los Angeles

Also Known As

K. Bornazyan, Krikor Bornazyan

31

Publications

1.8K

Citations

5

H-Index

10

Concepts

All Affiliations

University of California, Los Angeles
KB

About

Krikor Bornazyan is an author at University of California, Los Angeles specializing in radiation oncology, medicine, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

1.6K

2

Pathology

1

1

1.1K

3

Pharmacology

1

1

577

4

Radiation Medicine

1

1

1.1K

5

Cancer Therapeutics

1

1

1.1K

Krikor Bornazyan

×

4

Publications

1.8K

Citations

4

H-Index

YearCitations

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial

Narek Shaverdian, Aaron Lisberg, Krikor Bornazyan,

The Lancet Oncology

2017

1.1K

A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC

Aaron Lisberg, Amy L. Cummings, Jonathan W. Goldman,

Journal of Thoracic Oncology

2018

577

Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center

Aaron Lisberg, D. Andrew Tucker, Jonathan W. Goldman,

Cancer Immunology Research

2018

102

Low Concordance of Patient-Reported Outcomes With Clinical and Clinical Trial Documentation

Charlene M. Fares, Timothy J. Williamson, Matthew K. Theisen,

JCO Clinical Cancer Informatics

2018

25

Page 1